作者：
Tomasz K,Wojdacz [1]
;
Harindra E,Amarasinghe [2]
;
Latha,Kadalayil [3]
;
Alice,Beattie [2]
;
Jade,Forster [2]
;
Stuart J,Blakemore [4]
;
Helen,Parker [2]
;
Dean,Bryant [2]
;
Marta,Larrayoz [5]
;
Ruth,Clifford [6]
;
Pauline,Robbe [6]
;
Zadie A,Davis [7]
;
Monica,Else [8]
;
Dena R,Howard [9]
;
Basile,Stamatopoulos [10]
;
Andrew J,Steele [2]
;
Richard,Rosenquist [11]
;
Andrew,Collins [12]
;
Andrew R,Pettitt [13]
;
Peter,Hillmen [14]
;
Christoph,Plass [15]
;
Anna,Schuh [6]
;
Daniel,Catovsky [8]
;
David G,Oscier [7]
;
Matthew J J,Rose-Zerilli [2]
;
Christopher C,Oakes [16]
;
Jonathan C,Strefford [2]
作者单位：
Cancer Genomics, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Academic Unit of Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom.;Independent Clinical Epigenetics Laboratory, Pomeranian Medical University, Szczecin, Poland.;Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark.
[1]
Cancer Genomics, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Academic Unit of Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom.
[2]
Genetic Epidemiology and Bioinformatics, Faculty of Medicine, and.;Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
[3]
Cancer Genomics, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Academic Unit of Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom.;Department I of Internal Medicine, Centre of Excellence in Aging Research, University of Cologne, Cologne, Germany.
[4]
Cancer Genomics, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Academic Unit of Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom.;Division of Hemato-Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
[5]
Oxford National Institute for Health Research Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, United Kingdom.
[6]
Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
[7]
Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
[8]
Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.
[9]
Université Libre de Bruxelles, Laboratory of Clinical Cell Therapy, Jules Bordet Institute, Brussels, Belgium.
[10]
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
[11]
Genetic Epidemiology and Bioinformatics, Faculty of Medicine, and.
[12]
Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
[13]
Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
[14]
Division of Epigenomics and Cancer Risk Factors, The German Cancer Research Center, Heidelberg, Germany; and.
[15]
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
[16]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);染色体畸变(Chromosome Aberrations);计算生物学(Computational Biology);DNA甲基化(DNA Methylation);后成说, 遗传(Epigenesis, Genetic);表观基因组学(Epigenomics);女(雌)性(Female);基因表达谱(Gene Expression Profiling);基因表达调控, 白血病(Gene Expression Regulation, Leukemic);人类(Humans);免疫球蛋白重链(Immunoglobulin Heavy Chains);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤分期(Neoplasm Staging);预后(Prognosis);比例危险度模型(Proportional Hazards Models)
DOI
10.1182/bloodadvances.2019000237
PMID
31434681
发布时间
2024-07-19
换一批
换一批
